TITAN PHARMACEUTICALS INC — Director's Dealing 2005

Feb 9, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTP)
CIK: 0000910267
Period of Report: 2005-02-07

Reporting Person: FARRELL ROBERT EDWARD (Exec. VP and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-02-07	Stock Option (Right to Buy)	$2.62	A	45000	Acquired	2015-02-07	Common Stock (45000)	Direct

Footnotes

F1: Vests in two equal annual installments commencing one year from the date of grant.

F2: Not applicable.